Education
About Us
Working with TipRanks
Follow Us
Ilan Hadar Insider Profile
4 Followers
Ilan Hadar, CFO & Country Manager at Foamix Pharma, holds 65.47K shares in Silexion Therapeutics (Ticker: SLXN), holds 77.35K shares in VYNE Therapeutics (Ticker: VYNE), holds 130.58K shares in Foamix Pharma (Ticker: FOMX).
Ilan Hadar Foamix Pharma (FOMX)CFO & Country Manager
Foamix Pharma (FOMX)
CFO & Country Manager
Not Ranked
Ilan Hadar has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ilan Hadar holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ilan Hadar
Ilan Hadar's Trading History
Foamix Pharma
Feb 24, 2020
―
Uninformative Buy
―
$390.43K
VYNE Therapeutics
Mar 11, 2020
CFO and Country Manager
Uninformative Buy
―
$48.73K
Silexion Therapeutics
Feb 23, 2026
Chairman and CEO, Director
Uninformative Buy
―
$79.87K
List of latest transactions for each holding click on a transaction to see Ilan Hadar's performance on stock
You May Also Like
Ilan Hadar insider profile FAQ
What is the percentage of profitable transactions made by Ilan Hadar?
The percentage of profitable transactions made by Ilan Hadar is ―.
What is the average return per transaction made by Ilan Hadar?
The average return per transaction made by Ilan Hadar is ―.
What stocks does Ilan Hadar hold?
Ilan Hadar holds: FOMX, VYNE, SLXN stocks.
What was Ilan Hadar’s latest transaction?
Ilan Hadar latest transaction was an Uninformative Buy of ―.
What was Ilan Hadar's most profitable transaction?
Ilan Hadar’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ilan Hadar's role in Foamix Pharma?
Ilan Hadar's role in Foamix Pharma is CFO & Country Manager.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.